AbbVie Trials for Endometriosis Therapy Show Elagolix Reduces Heavy Menstrual Bleeding in Women with Uterine Fibroids
News
AbbVie’s investigational drug elagolix (ABT-620) decreased heavy menstrual bleeding and improved quality of life in women with uterine fibroids — a condition in which a part of the uterus muscle ... Read more